Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for irritable bowel syndrome
IRCT20150630022991N11Phase 4Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of sertraline in irritable bowel syndrome (IBS) (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Severity of irritable bowel syndrome symptoms and Quality of life. Started Jan 2018; status: completed.
02
Drugs
sertraline
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on IRCT20150630022991N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150630022991N11.